Thursday, 21 June 2018

Dr. Reddy's announces the launch of Tetrabenazine Tablets in U.S. Market

02 February 2018 | News

Tetrabenazine Tablets are available in strengths of 12.5 mg and 25 mg.

Image credit- wikipedia

Image credit- wikipedia

Dr. Reddy’s Laboratories Ltd has announced the launch of Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine (tetrabenazine) in the United States market approved by the U.S. Food and Drug Administration (USFDA).

The Xenazine brand and generic had U.S. sales of approximately $322 million MAT for the most recent twelve months ending in November 2017 according to IMS Health.

Dr. Reddy’s Tetrabenazine Tablets are available in strengths of 12.5 mg and 25 mg, each strength is available in a bottle count size of 112.

Xenazine is a registered trademark of Valeant Pharmaceuticals Luxembourg S.A.R.L.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Is India finding it difficult to handle Nipah?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls